Literature DB >> 11850779

Regulation of the human telomerase reverse transcriptase gene.

Anne-Lyse Ducrest1, Henrietta Szutorisz, Joachim Lingner, Markus Nabholz.   

Abstract

Most somatic human cells lack telomerase activity because they do not express the telomerase reverse transcriptase (hTERT) gene. Conversely, most cancer cells express hTERT and are telomerase positive. For most tumors it is not clear whether hTERT expression is due to their origin from telomerase positive stem cells or to reactivation of the gene during tumorigenesis. Telomerase negative cells lack detectable cytoplasmic and nuclear hTERT transcripts; in telomerase positive cells 0.2 to 6 mRNA molecules/cell can be detected. This suggests that expression is regulated by changes in the rate of hTERT gene transcription. In tumor cell lines hTERT expression behaves like a recessive trait, indicating that lack of expression in normal cells is due to one or several repressors. Studies with monochromosomal hybrids indicate that several chromosomes may code for such repressors. A number of transcription factors, tumor suppressors, cell cycle inhibitors, cell fate determining molecules, hormone receptors and viral proteins have been implicated in the control of hTERT expression; but these studies have not yet provided a clear explanation for the tumor specific expression of the hTERT gene, and the cis-acting elements which are the targets of repression in normal cells still have to be identified.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11850779     DOI: 10.1038/sj.onc.1205081

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  53 in total

Review 1.  Telomere structure, function and maintenance in Arabidopsis.

Authors:  Karel Riha; Dorothy E Shippen
Journal:  Chromosome Res       Date:  2003       Impact factor: 5.239

2.  Epigenetic landscape of the TERT promoter: a potential biomarker for high risk AML/MDS.

Authors:  Xin Zhao; Xin Tian; Sachiko Kajigaya; Caroline R Cantilena; Stephen Strickland; Bipin N Savani; Sanjay Mohan; Xingmin Feng; Keyvan Keyvanfar; Neil Dunavin; Danielle M Townsley; Bogdan Dumitriu; Minoo Battiwalla; Katayoun Rezvani; Neal S Young; A John Barrett; Sawa Ito
Journal:  Br J Haematol       Date:  2016-07-19       Impact factor: 6.998

Review 3.  Telomere biology: integrating chromosomal end protection with DNA damage response.

Authors:  Predrag Slijepcevic; Suliman Al-Wahiby
Journal:  Chromosoma       Date:  2005-10-15       Impact factor: 4.316

4.  Telomerase gene expression in the chicken: Telomerase RNA (TR) and reverse transcriptase (TERT) transcript profiles are tissue-specific and correlate with telomerase activity.

Authors:  Thomas H O'Hare; Mary E Delany
Journal:  Age (Dordr)       Date:  2006-02-17

Review 5.  Chromatin and epigenetic regulation of the telomerase reverse transcriptase gene.

Authors:  Jiyue Zhu; Yuanjun Zhao; Shuwen Wang
Journal:  Protein Cell       Date:  2010-02-07       Impact factor: 14.870

6.  Deletion of the telomerase reverse transcriptase gene and haploinsufficiency of telomere maintenance in Cri du chat syndrome.

Authors:  Anju Zhang; Chengyun Zheng; Mi Hou; Charlotta Lindvall; Ke-Jun Li; Fredrik Erlandsson; Magnus Björkholm; Astrid Gruber; Elisabeth Blennow; Dawei Xu
Journal:  Am J Hum Genet       Date:  2003-03-10       Impact factor: 11.025

7.  TELOMERASE ACTIVATOR1 induces telomerase activity and potentiates responses to auxin in Arabidopsis.

Authors:  Shuxin Ren; J Spencer Johnston; Dorothy E Shippen; Thomas D McKnight
Journal:  Plant Cell       Date:  2004-10-14       Impact factor: 11.277

8.  Multiple genetic variants in telomere pathway genes and breast cancer risk.

Authors:  Jing Shen; Marilie D Gammon; Hui-Chen Wu; Mary Beth Terry; Qiao Wang; Patrick T Bradshaw; Susan L Teitelbaum; Alfred I Neugut; Regina M Santella
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01       Impact factor: 4.254

9.  Association of hsp90 to the hTERT promoter is necessary for hTERT expression in human oral cancer cells.

Authors:  Reuben H Kim; Roy Kim; Wei Chen; Shen Hu; Ki-Hyuk Shin; No-Hee Park; Mo K Kang
Journal:  Carcinogenesis       Date:  2008-09-26       Impact factor: 4.944

10.  Upregulation of the Catalytic Telomerase Subunit by the Transcription Factor ER81 and Oncogenic HER2/Neu, Ras, or Raf.

Authors:  Basem S Goueli; Ralf Janknecht
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.